13 January 2020 1 3K Report

Hi,

I am trying to develop an assay to detect a conjugated peptide in plasma. I am essentially brand new to MS but have LC experience. The analyte of interest is a bisphosphonate tethered to parathyroid hormone (1-34) with a MW of 5868 (BP-PTH). Currently I am doing direct injections (no column) into a trip quad MS. I am able to detect the z=5, z=6, z=7 charged species of the conjugated peptide consistently.

However the problem arises when I use TMS-DAM to derivative the peptide by neutralizing the phosphate groups via methylation. We have discovered that the negatively charge bisphosphonate moieties actually bind to the metal tubing and metal columns in LC, which prevents accurate quantitation. Therefore, derivatization is required. I am able to get consistent detection and retention times (indicating no column binding) of the TMS-DAM derivatized BP-PTH in HPLC. When I use the derivatized BP-PTH with the phosphates methylated, I get much lower sensitivity in mass spec and I cannot get consistent precursor ions in Q1 scans. I get similar fragmentation each time, but it seems every new run the fragments have m/z values that differ in a range of +/- 15 m/z. The fragments are always similar in mass, but I can never get the exact same fragments to select precursor ions. The only consistent precursor ions I get is an intense peak at 306 m/z and 229 m/z. These are the only consistent peaks. Has anyone encountered this before? Why do I get all these issues once I derivatize?

Please look at the attached powerpoint. In the meantime I am trying to get connected with some LC-MS/MS experts at my university.

More Ben Wajda's questions See All
Similar questions and discussions